Abstract
Dendritic cells (DCs) have a central role in immune regulation, ranging from tolerance induction to the induction of specific immune responses. DCs serve as an essential link between innate and adaptive immunity. This broad range of powerful immune stimulatory as well as regulatory functions has made DCs as targets for vaccine development strategies. One approach to promote the tolerogenicity of DCs is to suppress their maturation by pharmacological agents, including glucocorticoids (GCs). In the present chapter we will review GCs used in vitro with cultured DCs, applied in vivo, or used to generate tolerogenic DCs for cellular therapy.
MeSH terms
-
Animals
-
Antigen Presentation / drug effects
-
Apoptosis / drug effects
-
Autoimmunity / drug effects
-
Cell Shape / drug effects
-
Cytokines / metabolism
-
Dendritic Cells / drug effects*
-
Dendritic Cells / immunology
-
Dendritic Cells / transplantation
-
Dexamethasone / pharmacology*
-
Graft Rejection / immunology
-
Graft Rejection / prevention & control*
-
Humans
-
Immune Tolerance / drug effects*
-
Immune Tolerance / genetics
-
Immunosuppressive Agents / pharmacology*
-
Immunotherapy, Adoptive
-
Inflammation / immunology
-
Inflammation / prevention & control*
-
Phenotype
-
Signal Transduction / drug effects
-
T-Lymphocytes / drug effects
-
T-Lymphocytes / immunology
Substances
-
Cytokines
-
Immunosuppressive Agents
-
Dexamethasone